The relative risk (i.e., risk ratio) of death between patients with high (>50%) and low (<50%) tumoral dysadherin protein level have been studied in esophageal squamous cell carcinoma (22) and gastric cancer (15) and these studies were used for the meta-analysis II (Figure 2B). This evidence concerns the gene FXYD5 and esophageal squamous cell carcinoma.